2.5 mg of tirzepatide Tirzeparo 2.5mg Mounjaro 2.5mg (Tirzepatide) Injection

We accept FSA and HSA

Semaglutide may be appropriate for adults who: Have type 2 diabetes with inadequate control on lower doses Struggle with obesity or weight-related metabolic issues Require improved insulin sensitivity Are seeking a medically supervised weight loss solution Want to reduce long-term cardiovascular risk This medication is not intended for individuals with type 1 diabetes or those without medical guidance

Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity

As a result, endometriotic cells could bypass the G2/M checkpoint and escape cell cycle arrest, promoting tumorigenesis and acquiring features of endometriosis progression

Oct 2016;41(10):1274-1280

It possesses neuroprotective properties that may help protect the nervous system